Office of Biostatistics Cytel Software

The contract involves the procurement of Cytel software for the Office of Biostatistics within the Food and Drug Administration, intended to support statistical review activities such as power and sample size calculations, adaptive trial designs using EAST software, and exact statistical calculations with StatXact. The need for the contract arises from the requirement for specialized software tools to enhance statistical analysis capabilities in regulatory review work. An increase in overall costs is noted, partly due to higher expenses associated with StatXact Procs integrated with SARGE (SAS), reflecting updated pricing or expanded software functionalities. This opportunity is categorized under the NAICS code 519130 and is currently listed as a forecast, with no specific solicitation number or set-aside details provided. The contract performance location is unspecified, and key contacts include a program liaison reachable via a provided FDA email, while the contracting officer has yet to be assigned. The contract's aim is to ensure that the Office of Biostatistics has the necessary software resources to maintain rigorous and precise regulatory statistical review processes.